Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer

Universitätsklinikum Hamburg-Eppendorf123 enrolled

Overview

Despite the availability of several preoperative diagnostic techniques, accurate pretreatment staging of esophageal cancer (EC) remains challenging. Therefore, The investigators evaluated the prognostic significance of circulating tumor cells (CTCs) in patients with EC.

Study Type

OBSERVATIONAL

Enrollment

123

Conditions

Resectable Esophageal Cancer

Interventions

esophagectomyPROCEDURE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * \> 18 years * resectable esophageal cancer Exclusion Criteria: * \< 18 years * esophageal cancer with preoperative distant metastases

Locations (1)

University Hospital Hamburg-Eppendorf

Hamburg, Germany

Outcomes

Primary Outcomes

overall survival

Time frame: 2 years

Secondary Outcomes

recurrence-free survival

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.